Options and Warrants - Schedule of Warrants Outstanding (Details) - Warrants [Member] - USD ($) |
3 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|
Jan. 31, 2024 |
Jan. 31, 2023 |
Apr. 30, 2025 |
Apr. 30, 2024 |
Jan. 31, 2025 |
Jan. 31, 2024 |
|
Schedule of Options and Warrants Outstanding [Line Items] | ||||||
Shares, Outstanding balance (in Shares) | 1,283,038 | 1,307,671 | 5,488,640 | 5,546,973 | 5,546,973 | 1,283,038 |
Exercise Price, Outstanding balance (in Dollars per share) | $ 5.88 | $ 6.43 | $ 6.42 | $ 6.37 | $ 6.37 | $ 5.88 |
Remaining Life, Outstanding balance | 2 years 11 months 19 days | 3 years 4 months 2 days | 3 years 11 months 23 days | 3 years 8 months 4 days | 3 years 8 months 4 days | 2 years 11 months 19 days |
Intrinsic Value, Outstanding balance | $ 2,531,538 | $ 10,626,018 | ||||
Shares, Exercisable (in Shares) | 5,488,640 | 5,546,973 | ||||
Exercise Price, Exercisable (in Dollars per share) | $ 6.42 | $ 6.37 | ||||
Remaining Life, Exercisable | 3 years 11 months 23 days | 3 years 8 months 4 days | ||||
Intrinsic Value, Exercisable | $ 2,531,538 | $ 10,626,018 | ||||
Shares, Granted (in Shares) | 4,402,460 | 4,402,460 | 175,833 | |||
Exercise Price, Granted (in Dollars per share) | $ 6.4 | $ 6.4 | $ 2.28 | |||
Remaining Life, Granted | 4 years 8 months 19 days | 4 years 8 months 19 days | 2 years 11 months 19 days | |||
Intrinsic Value, Granted | ||||||
Shares, Expired/Cancelled (in Shares) | (50,000) | (50,000) | (200,466) | |||
Exercise Price, Expired/Cancelled (in Dollars per share) | $ 4 | $ 4 | $ 6.33 | |||
Intrinsic Value, Expired/Cancelled | ||||||
Shares, Exercised (in Shares) | (58,333) | (88,525) | (88,525) | |||
Exercise Price, Exercised (in Dollars per share) | $ 1.93 | $ 1.98 | $ 1.98 | |||
Intrinsic Value, Exercised |
X | ||||||||||
- Definition Represents the shares of exercisable. No definition available.
|
X | ||||||||||
- Definition Represents the per share of exercisable. No definition available.
|
X | ||||||||||
- Definition Represents the per share of exercised. No definition available.
|
X | ||||||||||
- Definition Represents the per share of expired. No definition available.
|
X | ||||||||||
- Definition Represents the per share of granted. No definition available.
|
X | ||||||||||
- Definition Represents the amount of intrinsic value, exercisable. No definition available.
|
X | ||||||||||
- Definition Represents the amount of intrinsic value, exercised. No definition available.
|
X | ||||||||||
- Definition Represents the amount of intrinsic value, expired/cancelled. No definition available.
|
X | ||||||||||
- Definition Represents the amount of intrinsic value, granted. No definition available.
|
X | ||||||||||
- Definition Represents the per share of exercise price, outstanding balance. No definition available.
|
X | ||||||||||
- Definition Represents the value of intrinsic value, outstanding balance. No definition available.
|
X | ||||||||||
- Definition Represents the remaining life, exercisable. No definition available.
|
X | ||||||||||
- Definition Represents the duration of remaining lfe, granted. No definition available.
|
X | ||||||||||
- Definition Represents the duration of remaining life, outstanding balance. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|